Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024 at 15:45 PM EDT
Some patients with obstructive sleep apnea and obesity who took the highest dose of Zepbound achieved "disease resolution," in the two trials.
